YZFyzfpeptide.comSurvodutide2mgFor Research Use Only
1 / 1
Research product specification
SUR2
Survodutide
For Research Use Only. Not for human or veterinary use.
Survodutide is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 4 listed specifications. Review product codes, storage guidance and COA status, then request a wholesale quotation. Batch documentation is available on request.
Volume discounts are available for larger purchasing plans. Please contact us for a quotation.
Delivery includedUsually within 7 days after dispatch
Quality resolutionRefund or replacement when approved
24/7 contactWholesale assistance on WhatsApp
Product profile
About Survodutide
Survodutide (BI 456906) is a synthetic, innovative peptide and a dual agonist of the glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R). Its unique mechanism leverages synergistic pathways: GLP-1R agonism suppresses appetite and reduces energy intake by acting on circumventricular organs (CVOs) and satiety nuclei in the brain, while GCGR agonism directly promotes energy expenditure and lipolysis in peripheral tissues such as the liver. This dual action provides significant potential for weight reduction, glycemic control, and improvement of metabolic dysfunction-associated steatohepatitis (MASH). Currently in multiple Phase 3 trials, including the SYNCHRONIZE program, survodutide is being evaluated for its efficacy and cardiovascular safety in people with obesity and type 2 diabetes.
Main functions
1.Significant Weight Reduction: In the Phase 3 SYNCHRONIZE-1 trial, participants without diabetes achieved mean weight losses of 12% (3.6 mg) and 13% (6.0 mg) at 76 weeks, compared to 5% with placebo. Weight loss of up to 18.7% was reported in earlier Phase 2 studies.
2.Potent Glycemic Control: Meta-analyses show that survodutide significantly reduces HbA1c levels (mean reduction of -0.66%), with reductions up to -1.71% observed in patients with type 2 diabetes.
3.Improves Liver Health: In patients with MASH, survodutide has demonstrated significant reductions in liver fat and improvements in fibrosis, offering a novel therapeutic option for metabolic liver diseases.
4.Potential Cardiovascular and Renal Benefits: The mechanism involves reductions in visceral and epicardial adiposity and systemic inflammation. The large-scale SYNCHRONIZE-CVOT (enrolling 5,508 participants) is assessing long-term cardiovascular outcomes, with early signals suggesting potential renal protection.
5.Convenient Once-Weekly Dosing: As a long-acting molecule, it is administered via a once-weekly subcutaneous injection, enhancing treatment adherence.
Recommended audience
Individuals with obesity or overweight who require substantial weight loss, including those with suboptimal responses to existing therapies.
Patients with type 2 diabetes complicated by obesity, needing both potent glycemic control and significant weight reduction.
Individuals with MASH or those at risk of cardiovascular disease or chronic kidney disease.
Users seeking a next-generation, dual-target therapy that provides multiple metabolic and potential cardiovascular benefits.
Order formatOne box accepted
QuotationConfirmed on WhatsApp
DeliveryShipping and duties included
DocumentationPublished COA or available on request
Research product specification
Product information
Survodutide is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 4 listed specifications. Review product codes, storage guidance and COA status, then request a wholesale quotation. Batch documentation is available on request.
Handling information
Storage guidance
Keep unopened lyophilized products protected from light and moisture; store at 2-8°C short term or -20°C long term. After reconstitution, refrigerate according to product documentation and minimize freeze-thaw cycles.
Customer-first resolution
Report quality concerns within 14 days of delivery
Contact us with the order number, batch details and available photos. Opened products are accepted for review. When a quality claim is approved, you may choose a full refund or replacement shipment.
